AOP Orphan is a pioneer in the development, production and marketing of treatments for people with rare diseases also known as orphan diseases.
“Our team at AOP Orphan Pharmaceuticals FZ-LLC implements international strategies according to both local and global considerations. We boost AOP Orphan market presence by working closely with leading health care professionals and are dedicated to continuously supporting the best quality of life for patients with rare diseases!’
AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialisation of drugs for more than 20 years already.
Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Middle East health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases.
AOP Orphan Middle East was established in Dubai, UAE in September 2009 and transformed to FZ-LLC in 2017 to provide vitally important therapeutic drugs for specialized indications in the areas of HematoOncology, Neurology and Metabolic Disorders, covering the Gulf Region as well as the Middle East, North Africa and Asia.
AOP Orphan Pharmaceuticals FZ- LLC is a team of dedicated employees based in the United Arab Emirates Free zone, with a strong focus and specialization on marketing, sales and distribution of medicines for rare, orphan and complex diseases.